Zobrazeno 1 - 10
of 82
pro vyhledávání: '"David D. N'Da"'
Publikováno v:
ACS Omega, Vol 8, Iss 45, Pp 43088-43098 (2023)
Externí odkaz:
https://doaj.org/article/ee42e26c088b44f79fb0ee8b5e6bf789
Publikováno v:
Onderstepoort Journal of Veterinary Research, Vol 88, Iss 1, Pp e1-e8 (2021)
Toxoplasma gondii, an obligate intracellular parasite, is the aetiological agent of toxoplasmosis, a disease that affects approximately 25% – 30% of the world’s population. At present, no safe and effective vaccine exists for the prevention of to
Externí odkaz:
https://doaj.org/article/c9c609c5e7614fa498d99081e7049c48
Autor:
Keisuke Suganuma, David D. N’Da, Ken-ichi Watanabe, Yusuke Tanaka, Ehab Mossaad, Afraa Elata, Noboru Inoue, Shin-ichiro Kawazu
Publikováno v:
Pathogens, Vol 11, Iss 3, p 331 (2022)
Animal African trypanosomosis (AAT) leads to emaciation and low productivity in infected animals. Only six drugs are commercially available against AAT; they have severe side effects and face parasite resistance. Thus, the development of novel trypan
Externí odkaz:
https://doaj.org/article/833a3a13e7624f3791e7340288a0bf51
Autor:
Linous Munsimbwe, Anna Seetsi, Boniface Namangala, David D. N’Da, Noboru Inoue, Keisuke Suganuma
Publikováno v:
Molecules, Vol 26, Iss 11, p 3372 (2021)
African trypanosomes cause diseases in humans and livestock. Human African trypanosomiasis is caused by Trypanosoma brucei rhodesiense and T. b. gambiense. Animal trypanosomoses have major effects on livestock production and the economy in developing
Externí odkaz:
https://doaj.org/article/d0cd11c5b891466888936ff7a18e9ef4
Autor:
David D. N'Da
Publikováno v:
Molecules, Vol 19, Iss 12, Pp 20780-20807 (2014)
The transdermal application of drugs has attracted increasing interest over the last decade or so, due to the advantages it offers, compared to other delivery methods. The development of an efficient means of transdermal delivery can increase drug co
Externí odkaz:
https://doaj.org/article/ce81bb0e47074339a4c8fbe8135103ef
Publikováno v:
Acta Crystallographica Section E, Vol 66, Iss 8, Pp o2182-o2183 (2010)
The title compound, C17H27BrO5, DEB, is a derivative of artemisinin which is used in malara therapy. The OR-group at C12 is cis to the CH3-group at C11 and axially oriented on ring D which has a chair conformation. The crystal packing is stabilized b
Externí odkaz:
https://doaj.org/article/8abb2cee4c4c44e28d33ad8808ce8328
Autor:
Nadine Henning, Christina Kannigadu, Janine Aucamp, Helena D Janse van Rensburg, David D. N'Da
Leishmaniasis is a vector-borne, parasitic disease affecting millions of people and animals worldwide. Current therapeutic options have proven to be ineffective in both treating the disease and preventing its spread. As a result, new drugs must be de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c46288bd35f5ac4a560186b3cf96fa3
https://doi.org/10.21203/rs.3.rs-2910867/v1
https://doi.org/10.21203/rs.3.rs-2910867/v1
Autor:
Keitumetsi Ndlovu, Christina Kannigadu, Janine Aucamp, Helena D. Janse van Rensburg, David D. N'Da
Publikováno v:
Archiv der Pharmazie. 356
Publikováno v:
European journal of medicinal chemistry. 246
Leishmaniasis is a vector-borne parasitic disease that mostly affects populations in tropical and sub-tropical countries. There is currently no protective anti-leishmanial vaccine and only a paucity of clinical drugs is available to treat this diseas
Publikováno v:
Chemical biologydrug design. 100(2)
Leishmaniasis and cancer are two deadly diseases that plague the human population. There are a limited number of drugs available for the treatment of these diseases; however, their overuse has resulted in pathogenic resistance. Recent studies have in